Pulmonary Hypertension (PH) Completed Phase 2 Trials for Sildenafil (DB00203)

Also known as: Hypertension, Pulmonary / Pulmonary; Hypertension / Pulmonary hypertension / Hypertension Pulmonary / Pulmonary hypertensions / Pulmonary hypertension NOS

IndicationStatusPhase
DBCOND0051788 (Pulmonary Hypertension (PH))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00359736Sildenafil Study to Treat Idiopathic Pulmonary FibrosisTreatment
NCT00352482Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary HypertensionTreatment
NCT00334490Does Oral Sildenafil (Viagra) Decrease Mean Pulmonary Artery Pressure After Cardiac Surgery?Treatment
NCT01179334Evaluation of the Pharmacodynamic Effect of the Combination of Sildenafil and Riociguat on Blood Pressure and Other Safety Parameters.Treatment
NCT01481350Sildenafil for Post-capillary Pulmonary Hypertension in Patients Undergoing Cardiac SurgeryTreatment